本季度信息
医渡科技公布2026财年中期业绩，营收为人民币3.58亿元，同比上升8.7%。毛利率从上年同期的35.6%上升至37.4%。经营活动所用现金净额较上年同期的约1.17亿元显著收窄至约0.51亿元。
成本结构方面，销售及营销费用约占营收的20.5%，上年同期为22.0%；行政开支占营收比约为16.9%，上年同期为17.4%；研发投入占营收比约为23.7%，较上年同期28.4%有所下降。
业务分项
大数据平台和解决方案分部收入1.53亿元，同比上涨14.6%。公告解释，该板块增速主要受政策利好催化，订单规模明显扩大。 生命科学解决方案分部收入1.38亿元，同比下降4.4%。财报显示，主要由于部分项目推进节奏较上年同期有所放缓。 健康管理平台和解决方案分部收入0.67亿元，同比上涨30.3%，主要受核心城市“惠民保”项目参保人数持续增长带动。
高管解读
首席执行官徐济铭指出：“在全球医疗人工智能产业迈向关键整合阶段的大背景下，公司将继续深耕核心客户与关键业务，提高资源使用效率，加速推动核心算法引擎YiduCore在真实医疗场景的规模化应用。”
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.